��������

Christine Mendoza is an accomplished Principal Scientist with significant experience in the pharmaceutical industry. Currently at Amylin Pharmaceuticals since 2003, Christine has excelled in API Development, overseeing the clinical manufacturing of protein and peptide APIs and managing contract manufacturing organizations through various stages of process development. In a prior role at Amylin, Christine played a crucial role in transferring analytical assays for a commercial peptide drug product and contributed to achieving GMP Quality Control status in the internal development lab. Christine began their career at Corvas International, Inc., where management and scientific positions were held over a decade. Christine holds a Ph.D. in Biochemistry from the University of California, Berkeley, and a B.A. in Biochemistry from Rice University.